IMMUCELL CORP /DE/ Quarterly Deferred Tax Assets, Net of Valuation Allowance in USD from Q4 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Immucell Corp /De/ quarterly Deferred Tax Assets, Net of Valuation Allowance history and growth rate from Q4 2017 to Q3 2024.
  • Immucell Corp /De/ Deferred Tax Assets, Net of Valuation Allowance for the quarter ending September 30, 2024 was $0.000.
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $0 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $0 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $0 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $0 Dec 31, 2023 10-K 2024-04-01
Q2 2018 $563K Jun 30, 2018 10-Q 2018-11-13
Q4 2017 $473K Dec 31, 2017 10-K 2019-03-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.